基于单克隆抗体的生物技术制备

Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology) Pub Date : 2022-03-28 DOI:10.33920/med-13-2204-05

Igor Valerievich Korobkin

{"title":"基于单克隆抗体的生物技术制备","authors":"Igor Valerievich Korobkin","doi":"10.33920/med-13-2204-05","DOIUrl":null,"url":null,"abstract":"The current biopharmaceutical industry depends on the development of bioinformatics in the search and optimization of the properties of drugs. Compounds and their derivatives, whose metabolism influence, stability, and immunogenicity are confirmed by analytical and computational tools, are the candidates for becoming the drugs against antibodies.","PeriodicalId":12259,"journal":{"name":"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)","volume":"44 10 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biotechnological preparations based on monoclonal antibodies\",\"authors\":\"Igor Valerievich Korobkin\",\"doi\":\"10.33920/med-13-2204-05\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The current biopharmaceutical industry depends on the development of bioinformatics in the search and optimization of the properties of drugs. Compounds and their derivatives, whose metabolism influence, stability, and immunogenicity are confirmed by analytical and computational tools, are the candidates for becoming the drugs against antibodies.\",\"PeriodicalId\":12259,\"journal\":{\"name\":\"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)\",\"volume\":\"44 10 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33920/med-13-2204-05\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33920/med-13-2204-05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

当前的生物制药行业依赖于生物信息学的发展来寻找和优化药物的性质。化合物及其衍生物，其代谢影响、稳定性和免疫原性已被分析和计算工具证实，是抗抗体药物的候选者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Biotechnological preparations based on monoclonal antibodies

The current biopharmaceutical industry depends on the development of bioinformatics in the search and optimization of the properties of drugs. Compounds and their derivatives, whose metabolism influence, stability, and immunogenicity are confirmed by analytical and computational tools, are the candidates for becoming the drugs against antibodies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Farmacevticheskoe delo i tehnologija lekarstv (Pharmacy and Pharmaceutical Technology)

自引率

0.00%

发文量